Published on
CHOP earned top marks in meeting non-discrimination and training criteria that demonstrate its commitment to equitable, inclusive care for LGBT patients and their families.
Published on
CHOP announces the selection of Stephen P. Hunger, MD, a nationally prominent specialist in children’s cancer, as its new chief of the Division of Oncology and the director of the Center for Childhood Cancer Research.
Published on
CHOP and Penn Medicine experts are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations, setting the stage for a phase 3 clinical trial.
Published on
On Nov. 5, 2014, The Poison Control Center at The Children’s Hospital of Philadelphia and Einstein Healthcare Network hosted a city-wide Medical Toxicology Day.
Published on
CHOP and Temple share a $4.3 million NIH grant to explore new tools to eradicate HIV lurking in brain cells despite current antiviral treatments.
Published on
Subtle changes in mitochondria, our cells’ power plants, may trigger a broad range of common diseases, says a pioneering CHOP scientist.
Published on
Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) went into remission after receiving an investigational therapy, CTL019.
Published on
Thanks to the support of our donor community, the 2014 Four Seasons Parkway Run & Walk raised $1,275,000 for pediatric cancer research and care at CHOP. Watch the video of this year's event.
Published on
Holly L. Hedrick, MD, an attending surgeon in the Division of General, Thoracic and Fetal Surgery is named as the inaugural Louise Schnaufer Endowed Chair in Pediatric Surgery.
Published on
CHOP scientists helped identify gene mutations causing severe childhood epilepsy. The discovery broadens the potential for new therapies for the difficult-to-treat disease.